| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.074 | 0.7 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |